Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education Expand Collapse
    • Clinical Fellowships
    • Global Ophthalmology
    • Ophthalmology Clerkship
    • Orthoptist Training Program
    • Pre-Residency Fellowships
    • Residency Program
    • Vision Research Opportunities
    • Vision Research Training Program
    • Visiting Medical Students
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • Careers
  • People First
  • Events
  • Giving
  • News

eyes

Molecular dynamic simulations of nanomechanic chaperone peptide and effects of in silico His mutations on nanostructured function.

Posted on November 1, 2008

PubMed ID: 18683277 Author(s): Barzegar A, Moosavi-Movahedi AA, Mahnam K, Bahrami H, Sheibani N. Molecular dynamic simulations of nanomechanic chaperone peptide and effects of in silico His mutations on nanostructured function. J Pept Sci. 2008 …

Posted in Publications, Sheibani Lab

Diabetic macular edema: what is focal and what is diffuse?

Posted on November 1, 2008

PubMed ID: 18774122 Author(s): Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU; Diabetic Retinopathy Clinical Research Network. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008 Nov;146(5):649-55, 655.e1-6. …

Posted in Michael Altaweel, Publications, WRC

Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study.

Posted on November 1, 2008

PubMed ID: 19001224 Author(s): Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 2008 Nov;126(11):1554-60. doi: …

Posted in Kleins Lab, Publications

Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters.

Posted on November 1, 2008

PubMed ID: 18831064 Author(s): Schneider A, Bardakjian TM, Zhou J, Hughes N, Keep R, Dorsainville D, Kherani F, Katowitz J, Schimmenti LA, Hummel M, Fitzpatrick DR, Young TL. Familial recurrence of SOX2 anophthalmia syndrome: phenotypically …

Posted in Publications, Young Lab

A severity scale for diabetic macular edema developed from ETDRS data.

Posted on November 1, 2008

PubMed ID: 18539929 Author(s): Gangnon RE, Davis MD, Hubbard LD, Aiello LM, Chew EY, Ferris FL 3rd, Fisher MR; Early Treatment Diabetic Retinopathy Study Research Group. A severity scale for diabetic macular edema developed from …

Posted in Matthew Davis, Publications

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.

Posted on November 1, 2008

PubMed ID: 19068374 Author(s): Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008 …

Posted in Kleins Lab, Publications

The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.

Posted on November 1, 2008

PubMed ID: 18672224 Author(s): Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008 Nov;146(5):692-9. doi: 10.1016/j.ajo.2008.05.050. Epub 2008 Jul …

Posted in Kleins Lab, Publications

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Posted on October 18, 2008

PubMed ID: 18823656 Author(s): Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) …

Posted in Kleins Lab, Publications

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Posted on October 18, 2008

PubMed ID: 18823658 Author(s): Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type …

Posted in Kleins Lab, Publications
  • Previous page
  • 1
  • 305
  • 306
  • You're on page 307
  • 308
  • 309
  • 618
  • Next page

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.